BioCentury
ARTICLE | Company News

Ziopharm, Solasia in deal for darinaparsin

March 8, 2011 1:26 AM UTC

Ziopharm Oncology Inc. (NASDAQ:ZIOP) granted Solasia Pharma K.K. (Tokyo, Japan) exclusive rights to develop and commercialize IV and oral darinaparsin in 13 Asia-Pacific territories. The IV organic ar...